INTELGENX
IntelGenx is a oral drug delivery company primarily focused on the development and manufacturing of innovative pharmaceutical oral films based on its proprietary VersaFilm™ technology platform. It provides comprehensive pharmaceuticals services to pharmaceutical partners, including R&D, analytical method development, clinical monitoring, IP and regulatory services. IntelGenx’s state-of-the-art manufacturing facility, established for the VersaFilm™ technology platform, supports lab-scale to pilot and commercial-scale production, offering full service capabilities to its clients.
INTELGENX
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2003-01-01
Address:
Saint Laurent, Quebec, Canada
Country:
Canada
Website Url:
http://www.intelgenx.com
Total Employee:
11+
Status:
Active
Contact:
(514)331-7440
Email Addresses:
[email protected]
Total Funding:
33.56 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Google Universal Analytics
Similar Organizations
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Employees Featured
Founder
Stock Details
Investors List
ATAI Life Sciences
ATAI Life Sciences investment in Post-IPO Debt - IntelGenX
ATAI Life Sciences
ATAI Life Sciences investment in Post-IPO Equity - IntelGenX
ATAI Life Sciences
ATAI Life Sciences investment in Post-IPO Debt - IntelGenX
Official Site Inspections
http://www.intelgenx.com
- Host name: parking1.whc.ca
- IP address: 149.56.225.6
- Location: Montreal Canada
- Latitude: 45.5063
- Longitude: -73.5794
- Timezone: America/Toronto
- Postal: H3A
More informations about "IntelGenX"
IntelGenx Announces Rebranding to Nualtis, Signaling
Jun 11, 2025 As Nualtis, the organization is positioned to deliver great value to partners through lifecycle extension, accelerated development timelines, and differentiated drug delivery.See details»
IntelGenx Announces Organizational Changes to Support Global …
Apr 20, 2023 SAINT LAURENT, Quebec, April 13, 2023 (GLOBE NEWSWIRE) — IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (the “Company” or “IntelGenx”) today …See details»
IntelGenX - Crunchbase Company Profile & Funding
IntelGenX is an oral drug delivery company primarily that focuses on the development and manufacturing of pharmaceutical oral films.See details»
IntelGenX - Psychedelic Science Review
IntelGenX IntelGenX is a drug delivery technology company based in Montreal. It was founded in 2003 by its Chief Executive Officer, Dr. Horst Zerbe. The company specializes in developing and commercially producing dissolvable …See details»
IntelGenx Technologies Corp. - AnnualReports.com
IntelGenx is a leading oral drug delivery company focused on the development and manufacturing of innovative pharmaceutical oral films based on its …See details»
IntelGenx Technologies (IGXT) Company Profile & Description
May 16, 2024 Company profile for IntelGenx Technologies Corp. (IGXT) with a description, list of executives, contact details and other key facts.See details»
IntelGenx - IntelGenx Announces Organizational Changes to …
IntelGenx's highly skilled team provides comprehensive pharmaceuticals services to pharmaceutical partners, including R&D, analytical method development, clinical monitoring, …See details»
IntelGenx Company Profile - Office Locations, Competitors ... - Craft
Nov 10, 2021 IntelGenx has 5 employees at their 1 location and $1.04 m in annual revenue in FY 2023. See insights on IntelGenx including office locations, competitors, revenue, financials, …See details»
IntelGenx Technologies - Overview, News & Similar companies
May 8, 2024 View IntelGenx Technologies (www.intelgenx.com) location in Quebec, Canada , revenue, industry and description. Find related and similar companies as well as employees …See details»
IntelGenx Corp. - Drug pipelines, Patents, Clinical trials - Synapse
May 8, 2025 Intelgenx Corp. is a company that specializes in creating oral-controlled release pharmaceutical products. They provide a range of services to pharmaceutical partners, such …See details»
IntelGenx Announces Organizational Changes to Support Global …
Apr 13, 2023 SAINT LAURENT, Quebec, April 13, 2023 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (the "Company" or "IntelGenx") today …See details»
IntelGenx Announces Rebranding to Nualtis, Signaling Strategic ...
MONTREAL, June 11, 2025 (GLOBE NEWSWIRE) — IntelGenx, a leader in oral thin film drug delivery, today announced its official rebrand to Nualtis, marking a pivotal step in the …See details»
IntelGenx makes organizational changes to support global growth ...
Apr 13, 2023 IntelGenx Technologies (TSX:IGX; OTCQB:IGXT) appointed Dwight Gorham as CEO, effective immediately, succeeding the company’s founder, Horst Zerbe, Ph.D., who has …See details»
IntelGenX - businessabc.net
Feb 25, 2025 IntelGenX was founded in 2006 and is a publicly traded company on the TSX Venture Exchange, trading under the symbol “IGX”. The company has over 10 years of …See details»
Intelgenx Corp. Company Profile | Saint-Laurent, QC, Canada ...
Find company research, competitor information, contact details & financial data for Intelgenx Corp. of Saint-Laurent, QC. Get the latest business insights from Dun & Bradstreet.See details»
Intelgenx Technologies 2025 Company Profile: Valuation, Investors ...
Intelgenx Technologies Corp is an oral drug delivery company. The company is focused on the development and manufacturing of pharmaceutical oral films based on its proprietary …See details»
IntelGenx Corp - PharmaSource
IntelGenx Corp is a CMO/CDMO company operating in the pharmaceutical industry. IntelGenx helps pharmaceutical companies improve drug delivery, provide tangible clinical and …See details»
IntelGenx Initiates Restructuring Proceedings Under the CCAA to ...
May 17, 2024 Since its inception, IntelGenx has funded its operations primarily through public and private equity offerings, loans from business partners and research and development …See details»
IntelGenx Announces a Change to its Board of Directors
Jul 21, 2023 IntelGenx’s highly skilled team provides comprehensive pharmaceuticals services to pharmaceutical partners, including R&D, analytical method development, clinical monitoring, …See details»
IntelGenx Initiates Restructuring Proceedings Under the CCAA to ...
May 17, 2024 After a careful review of all available alternatives and following thorough consultation with its legal and financial advisors, the Company’s Board of Directors determined …See details»